Earnings History Data for Aligos Therapeutics, Inc. (ALGS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company. It is focused on the development of antiviral therapies for chronic hepatitis B and coronaviruses as well as liver diseases. Aligos Therapeutics, Inc. is based in SAN FRANCISCO, Calif.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
12-03-2024 AH ALGS Aligos Therapeutics, Inc. 62.95 -0.22 -0.27 -0.51 Aligos Therapeutics GAAP EPS of -$0.22 beats by $0.05, revenue of $2.68M beats by $1.08M
[3/12/2024 4:16 PM]
0.8750 0.0 
(0.57%)
0.87 0.0 
(0.00%)
0.54 - 1.51 1,277,537 460,000 3,513
02-11-2023 AH ALGS Aligos Therapeutics, Inc. 26.10 -0.41 -0.48 -0.44 Aligos Therapeutics GAAP EPS of -$0.41
[11/2/2023 4:51 PM]
0.7603 0.01 
(1.37%)
0.73 -0.02 
(-2.80%)
0.54 - 2.41 86,409 220,000 12,039
03-08-2023 AH ALGS Aligos Therapeutics, Inc. 37.79 -0.43 -0.50 -0.47 Aligos Therapeutics GAAP EPS of -$0.43 beats by $0.06, revenue of $2.59M
[8/3/2023 5:59 PM]
0.8850 0.0 
(-0.55%)
0.91 0.02 
(2.25%)
0.84 - 2.41 23,495 90,000 204
04-05-2023 AH 4:05 PM ET
(May 4)
ALGS Aligos Therapeutics, Inc. 51.96 -0.53 -0.47 -0.84 Aligos Therapeutics GAAP EPS of -$0.53 misses by $0.05, revenue of $2.58M
[5/4/2023 5:25 PM]
1.24 -0.12 
(-8.82%)
1.37 0.01 
(0.74%)
0.84 - 2.41 111,402 70,000 3,006
09-03-2023 AH 4:05 PM ET
(Mar 9)
ALGS Aligos Therapeutics, Inc. 70.65 -0.51 -0.49 -0.89 Aligos Therapeutics GAAP EPS of -$0.51 misses by $0.02, revenue of $3.54M beats by $1.39M
[3/9/2023 4:46 PM]
1.30 -0.06 
(-4.41%)
1.36 0.0 
(0.00%)
0.84 - 2.99 157,113 80,000 100
02-11-2022 AH 4:05 PM ET
(Nov 2)
ALGS Aligos Therapeutics, Inc. 44.95 -0.44 -0.57 -0.78 Aligos Therapeutics GAAP EPS of -$0.44 beats by $0.14, revenue of $4.12M beats by $3.37M
[11/2/2022 4:51 PM]
1.04 -0.03 
(-2.80%)
1.12 0.05 
(4.67%)
0.98 - 17.97 20,134 40,000 500
04-08-2022 AH 4:05 PM ET
(Aug 4)
ALGS Aligos Therapeutics, Inc. 61.05 -0.47 -0.65 -0.79 Aligos Therapeutics GAAP EPS of -$0.47 beats by $0.18, revenue of $3.69M
[8/4/2022 4:52 PM]
1.50 0.11 
(7.91%)
1.45 0.06 
(4.32%)
1.03 - 17.97 120,414 80,000 860
04-05-2022 AH 4:05 PM ET
(May 4)
ALGS Aligos Therapeutics 50.00 -0.84 -0.66 0.00 Aligos Therapeutics GAAP EPS of -$0.84, revenue of $2.57M
[5/4/2022 5:20 PM]
1.09 -0.15 
(-12.09%)
1.15 -0.09 
(-7.26%)
1.07 - 34.31 371,412 210,000 57,207
10-03-2022 AH 4:05 PM ET
(Mar 10)
ALGS Aligos Therapeutics, Inc. 108.67 -0.89 -0.82 -1.09 Aligos Therapeutics GAAP EPS of -$0.89 misses by $0.06
[3/10/2022 4:31 PM]
2.59 0.14 
(5.71%)
2.57 0.12 
(4.90%)
2.11 - 34.31 229,598 330,000 17,130
04-11-2021 AH 4:05 PM ET
(Nov 4)
ALGS Aligos Therapeutics, Inc. 682.59 -0.78 -0.83 0.00 Aligos Therapeutics EPS beats by $0.03
[11/4/2021 5:23 PM]
16.85 0.89 
(5.58%)
15.75 0.0 
(0.00%)
13.30 - 37.51 139,551 170,000 3,892
05-08-2021 AH 4:05 PM ET
(Aug 5)
ALGS Aligos Therapeutics, Inc. 662.14 -0.79 -0.81 0.00 Aligos Therapeutics EPS beats by $0.02
[8/5/2021 4:44 PM]
15.93 -0.30 
(-1.85%)
16.23 0.0 
(0.00%)
12.82 - 37.51 210,543 290,000 471
10-05-2021 AH 4:05 PM ET
(May 10)
ALGS Aligos Therapeutics, Inc. 1,030 -0.74 -0.90 0.00 Aligos Therapeutics EPS beats by $0.16
[5/10/2021 4:57 PM]
26.37 1.34 
(5.35%)
0.0 0.0 
(0.00%)
12.82 - 37.51 66,126 60,000 0